Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -850.13% is 122% below its 5-year average of -382.60%, around the middle of its 5-year range (-2192.16%–69.40%).
13.84% above its 12-month average of -986.64%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -692.47%.
NET PROFIT MARGIN
-850.13%
NET PROFIT MARGIN AVG TTM
-986.64%
NET PROFIT MARGIN AVG 3Y
-446.97%
NET PROFIT MARGIN AVG 5Y
-382.60%
NET PROFIT MARGIN AVG 10Y
-480.07%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+13.84%
CURRENT VS 3Y AVG
-90.20%
CURRENT VS 5Y AVG
-122.20%
CURRENT VS 10Y AVG
-77.08%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 735 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Alector, Inc.
Market Cap
$216.59M
Net Profit Margin
-850.13%
TTM Avg
-986.64%
3Y Avg
-446.97%
5Y Avg
-382.60%
Market Cap
$215.15M
Net Profit Margin
-920285.19%
TTM Avg
-662320.41%
3Y Avg
-376335.80%
5Y Avg
-251721.50%
Market Cap
$214.63M
Net Profit Margin
74.06%
TTM Avg
51.52%
3Y Avg
44.79%
5Y Avg
47.28%
Market Cap
$214.34M
Net Profit Margin
12.39%
TTM Avg
11.00%
3Y Avg
-1.71%
5Y Avg
-13.45%
Market Cap
$214.21M
Net Profit Margin
-269.75%
TTM Avg
-1318.17%
3Y Avg
-659.09%
5Y Avg
-439.39%
Market Cap
$223.62M
Net Profit Margin
-553.88%
TTM Avg
-2620.95%
3Y Avg
-26640.28%
5Y Avg
-17808.90%
Market Cap
$213.22M
Net Profit Margin
47.55%
TTM Avg
-1.25%
3Y Avg
-126.95%
5Y Avg
-427.13%
Market Cap
$209.49M
Net Profit Margin
-10422.48%
TTM Avg
-2428.80%
3Y Avg
-1417.64%
5Y Avg
-1019.29%
Market Cap
$228.93M
Net Profit Margin
-171.72%
TTM Avg
-262.44%
3Y Avg
-337.71%
5Y Avg
-348.92%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alector, Inc. (ALEC) | $216.59M | -850.13% | -986.64% | -446.97% | -382.60% |
| Lyell Immunopharma, Inc. (LYEL)vs › | $215.15M | -920285.19% | -662320.41% | -376335.80% | -251721.50% |
| Anbio Biotechnology Class A Ordinary Shares (NNNN)vs › | $214.63M | 74.06% | 51.52% | 44.79% | 47.28% |
| Niagen Bioscience Inc (NAGE)vs › | $214.34M | 12.39% | 11.00% | -1.71% | -13.45% |
| Prelude Therapeutics Incorporated (PRLD)vs › | $214.21M | -269.75% | -1318.17% | -659.09% | -439.39% |
| Keros Therapeutics, Inc. (KROS)vs › | $223.62M | -553.88% | -2620.95% | -26640.28% | -17808.90% |
| Compugen Ltd. (CGEN)vs › | $213.22M | 47.55% | -1.25% | -126.95% | -427.13% |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $209.49M | -10422.48% | -2428.80% | -1417.64% | -1019.29% |
| Profound Medical Corp. (PROF)vs › | $228.93M | -171.72% | -262.44% | -337.71% | -348.92% |
| Biodesix, Inc. (BDSX)vs › | $229.96M | -26.97% | -50.02% | -94.39% | -87.59% |
Operating Margin
-692.8%
Net Profit Margin
-850.1%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -692.47% |
| 2026-03-31 | -2192.16% |
| 2025-12-31 | -597.51% |
| 2025-09-30 | -1063.40% |
| 2025-06-30 | -387.66% |
| 2025-03-31 | -1101.55% |
| 2024-12-31 | -3.82% |
| 2024-09-30 | -275.19% |
| 2024-06-30 | -256.42% |
| 2024-03-31 | -227.01% |
| 2023-12-31 | -272.77% |
| 2023-09-30 | -488.25% |
| 2023-06-30 | 2.45% |
| 2023-03-31 | -277.10% |
| 2022-12-31 | -363.07% |
| 2022-09-30 | -310.72% |
| 2022-06-30 | 12.38% |
| 2022-03-31 | -182.30% |
| 2021-12-31 | -397.37% |
| 2021-09-30 | 69.40% |
| 2021-06-30 | -839.63% |
| 2021-03-31 | -1269.37% |
| 2020-12-31 | -1075.19% |
| 2020-09-30 | -892.68% |
| 2020-06-30 | -1429.84% |
| 2020-03-31 | -558.07% |
| 2019-12-31 | -508.70% |
| 2019-09-30 | -1177.23% |
| 2019-06-30 | -355.07% |
| 2019-03-31 | -331.13% |
| 2018-12-31 | -189.97% |
| 2018-09-30 | -235.54% |
| 2018-06-30 | -156.44% |
| 2018-03-31 | -171.48% |
| 2017-12-31 | -319.65% |
| 2017-09-30 | -6557.52% |
| 2017-06-30 | -2422.37% |
| 2017-03-31 | -2422.37% |
